Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

[A phase I study of combination-therapy with gemcitabine and epitope peptides derived from human vascular endothelial growth factor receptor for unresectable or recurrent pancreas cancer].

Kim DH, Shiozawa S, Usui T, Yoshimatsu K, Otani T, Tsunoda T, Nakamura Y, Ogawa K. [A phase I study of combination-therapy with gemcitabine and epitope peptides derived from human vascular endothelial growth factor receptor for unresectable or recurrent pancreas cancer]. Gan To Kagaku Ryoho. 2008 Nov; 35(12):2271-3.

View in: PubMed

collapse authors with profiles